Hanmi Pharmaceutical Co., Ltd.

Insider Reports History

Location
Seoul, Korea, Republic of
Signature
HANMI PHARMACEUTICAL CO., LTD.; By: /s/ Haegon Shin, Managing Director, Global Business Division
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hanmi Pharmaceutical Co., Ltd.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aptose Biosciences Inc. 10%+ Owner Common Shares 508,710 $101,742 $0.2000 18 Mar 2025 Direct

Insider Reports Filed by Hanmi Pharmaceutical Co., Ltd.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APTOF Aptose Biosciences Inc. 18 Mar 2025 0 $0 3 10%+ Owner 20 Mar 2025, 20:54